vs
AerSale Corp（ASLE）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
AerSale Corp的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$90.9M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 5.9%，领先378.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -4.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 0.2%）
AerSale Corp总部位于美国佛罗里达州多拉市，是一家面向航空领域的全球供应商，主要为客运及货运航空公司、政府机构、跨国整机制造商与独立维修机构提供商用喷气飞机二手整机、发动机、航空耗材，并提供航空工程服务，同时该公司也是飞机机队回收协会的成员企业。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ASLE vs RIGL — 直观对比
营收规模更大
ASLE
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出25.2%
-4.0%
净利率更高
RIGL
高出378.1%
5.9%
两年增速更快
RIGL
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $90.9M | $69.8M |
| 净利润 | $5.4M | $268.1M |
| 毛利率 | 34.1% | 91.5% |
| 营业利润率 | 7.8% | 33.2% |
| 净利率 | 5.9% | 384.0% |
| 营收同比 | -4.0% | 21.2% |
| 净利润同比 | 99.7% | 1769.2% |
| 每股收益（稀释后） | $0.10 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASLERIGL
| Q4 25 | $90.9M | $69.8M | ||
| Q3 25 | $71.2M | $69.5M | ||
| Q2 25 | $107.4M | $101.7M | ||
| Q1 25 | $65.8M | $53.3M | ||
| Q4 24 | $94.7M | $57.6M | ||
| Q3 24 | $82.7M | $55.3M | ||
| Q2 24 | $77.1M | $36.8M | ||
| Q1 24 | $90.5M | $29.5M |
净利润ASLERIGL
| Q4 25 | $5.4M | $268.1M | ||
| Q3 25 | $-120.0K | $27.9M | ||
| Q2 25 | $8.6M | $59.6M | ||
| Q1 25 | $-5.3M | $11.4M | ||
| Q4 24 | $2.7M | $14.3M | ||
| Q3 24 | $509.0K | $12.4M | ||
| Q2 24 | $-3.6M | $-1.0M | ||
| Q1 24 | $6.3M | $-8.2M |
毛利率ASLERIGL
| Q4 25 | 34.1% | 91.5% | ||
| Q3 25 | 30.2% | 93.2% | ||
| Q2 25 | 32.9% | 95.6% | ||
| Q1 25 | 27.3% | 91.7% | ||
| Q4 24 | 31.4% | 89.9% | ||
| Q3 24 | 28.6% | 85.5% | ||
| Q2 24 | 28.2% | 92.4% | ||
| Q1 24 | 31.8% | 93.1% |
营业利润率ASLERIGL
| Q4 25 | 7.8% | 33.2% | ||
| Q3 25 | 4.0% | 40.9% | ||
| Q2 25 | 11.7% | 60.1% | ||
| Q1 25 | -10.1% | 23.9% | ||
| Q4 24 | 5.2% | 28.9% | ||
| Q3 24 | 2.4% | 25.4% | ||
| Q2 24 | -2.4% | 1.2% | ||
| Q1 24 | 5.2% | -23.6% |
净利率ASLERIGL
| Q4 25 | 5.9% | 384.0% | ||
| Q3 25 | -0.2% | 40.2% | ||
| Q2 25 | 8.0% | 58.6% | ||
| Q1 25 | -8.0% | 21.5% | ||
| Q4 24 | 2.9% | 24.9% | ||
| Q3 24 | 0.6% | 22.5% | ||
| Q2 24 | -4.7% | -2.8% | ||
| Q1 24 | 6.9% | -27.9% |
每股收益（稀释后）ASLERIGL
| Q4 25 | $0.10 | $14.11 | ||
| Q3 25 | $0.00 | $1.46 | ||
| Q2 25 | $0.18 | $3.28 | ||
| Q1 25 | $-0.10 | $0.63 | ||
| Q4 24 | $0.05 | $0.82 | ||
| Q3 24 | $0.01 | $0.70 | ||
| Q2 24 | $-0.07 | $-0.06 | ||
| Q1 24 | $0.12 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.4M | $155.0M |
| 总债务越低越好 | $1.3M | $52.5M |
| 股东权益账面价值 | $424.4M | $391.5M |
| 总资产 | $640.5M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ASLERIGL
| Q4 25 | $4.4M | $155.0M | ||
| Q3 25 | $5.3M | $137.1M | ||
| Q2 25 | $5.7M | $108.4M | ||
| Q1 25 | $4.7M | $77.1M | ||
| Q4 24 | $4.7M | $77.3M | ||
| Q3 24 | $9.8M | $61.1M | ||
| Q2 24 | $4.3M | $49.1M | ||
| Q1 24 | $2.6M | $49.5M |
总债务ASLERIGL
| Q4 25 | $1.3M | $52.5M | ||
| Q3 25 | $1.5M | $60.0M | ||
| Q2 25 | $907.0K | $60.0M | ||
| Q1 25 | $1.1M | $60.0M | ||
| Q4 24 | $1.2M | $60.0M | ||
| Q3 24 | $376.0K | $60.0M | ||
| Q2 24 | $522.0K | $60.0M | ||
| Q1 24 | $3.5M | $60.0M |
股东权益ASLERIGL
| Q4 25 | $424.4M | $391.5M | ||
| Q3 25 | $417.1M | $117.6M | ||
| Q2 25 | $415.9M | $81.9M | ||
| Q1 25 | $406.5M | $18.6M | ||
| Q4 24 | $455.6M | $3.3M | ||
| Q3 24 | $451.5M | $-14.6M | ||
| Q2 24 | $449.8M | $-29.9M | ||
| Q1 24 | $452.0M | $-31.7M |
总资产ASLERIGL
| Q4 25 | $640.5M | $513.6M | ||
| Q3 25 | $646.3M | $242.5M | ||
| Q2 25 | $646.7M | $206.7M | ||
| Q1 25 | $646.1M | $176.0M | ||
| Q4 24 | $604.7M | $164.0M | ||
| Q3 24 | $601.5M | $139.4M | ||
| Q2 24 | $598.7M | $128.4M | ||
| Q1 24 | $571.7M | $126.5M |
负债/权益比ASLERIGL
| Q4 25 | 0.00× | 0.13× | ||
| Q3 25 | 0.00× | 0.51× | ||
| Q2 25 | 0.00× | 0.73× | ||
| Q1 25 | 0.00× | 3.23× | ||
| Q4 24 | 0.00× | 18.25× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $9.8M | — |
| 自由现金流率自由现金流/营收 | 10.8% | — |
| 资本支出强度资本支出/营收 | 1.7% | — |
| 现金转化率经营现金流/净利润 | 2.11× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-29.1M | — |
8季度趋势，按日历期对齐
经营现金流ASLERIGL
| Q4 25 | $11.4M | $22.0M | ||
| Q3 25 | $-8.9M | $24.0M | ||
| Q2 25 | $19.8M | $30.5M | ||
| Q1 25 | $-45.2M | $-893.0K | ||
| Q4 24 | $37.5M | $14.5M | ||
| Q3 24 | $10.4M | $21.7M | ||
| Q2 24 | $-15.3M | $302.0K | ||
| Q1 24 | $-21.5M | $-5.0M |
自由现金流ASLERIGL
| Q4 25 | $9.8M | — | ||
| Q3 25 | $-9.8M | — | ||
| Q2 25 | $18.6M | — | ||
| Q1 25 | $-47.6M | — | ||
| Q4 24 | $32.3M | — | ||
| Q3 24 | $8.9M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-25.0M | — |
自由现金流率ASLERIGL
| Q4 25 | 10.8% | — | ||
| Q3 25 | -13.8% | — | ||
| Q2 25 | 17.3% | — | ||
| Q1 25 | -72.4% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | -24.6% | — | ||
| Q1 24 | -27.7% | — |
资本支出强度ASLERIGL
| Q4 25 | 1.7% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 3.9% | — |
现金转化率ASLERIGL
| Q4 25 | 2.11× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 2.31× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 13.89× | 1.01× | ||
| Q3 24 | 20.52× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
RIGL
暂无分部数据
